Transferrina y ceruloplasmina en orina de pacientes con lupus eritematoso sistémico. ¿Son útiles para diferenciar pacientes con nefritis lúpica? Tomás Urrego; Blanca Ortiz-Reyes; Adriana L. Vanegas-García; Carlos H. Muñoz; Luis A. González; Gloria Vásquez; José A. Gómez-Puerta;

Impact of the COVID-19 pandemic on psychosocial health in rheumatic patients: A longitudinal study Laura Cano-García; Sara Manrique-Arija; Rocío Redondo-Rodríguez; Marta Vera-Ruiz; Jose Manuel Lisbona-Montañez; Arkaitz Mucientes-Ruiz; Aimara García-Studer; Fernando Ortiz-Marquez; Natalia Mena-Vázquez; Antonio Fernández-Nebro;

Investigating potential biomarkers and therapeutic targets for patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) through the utilization of cytokine profiling Akhil Akhil; Rohit Bansal; Jyotsana Kaushal; Aman Sharma; Archana Bhatnagar;